becton dickinson compani
summari summari report ep beat
expect despit slight top-lin miss reiter
guidanc call manag disclos fda
issu non-approv letter lutonix btk knee
indic non-approv decis surpris
us pipelin setback coupl uncertain futur
swatch patch pump disappoint despit continu lutonix
headwind howev continu target sale growth
sound confid deliv double-digit report ep
growth believ outlook reason although potenti
upsid may cap due loss gore royalti
ep forecast sale growth year ep
respect lower
price target base blend
ep estim ebitda estim
lutonix btk non-approv surpris us call
manag disclos fda issu non-
approv letter lutonix btk recal compani previous
push approv previou assumpt plan
meet fda soon discuss next step pipelin
setback disappoint consist
expect chanc btk approv due on-going safeti
concern paclitaxel coat devic note lutonix
btk pma remain activ sever option provid
addit data fda lutonix btk sale model
target sale growth double-digit report ep growth
outlook assum materi bounc back
deterior lutonix sale approv indic
outlook seem reason believ potenti upsid may
limit given expir gore royalti manag seem
confid ep grow doubl digit even fx
headwind accord magnitud fx headwind
potenti lutonix btk contribut determin low vs high
end ep growth rang estim gore royalti total
nearli ep translat
ep growth headwind like
potenti offset addit debt repay possibl
lower tax rate lack visibl possibl offset
exampl estim everi increment debt pay
would translat addit ep maintain
sale growth forecast lower ep estim
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
includ bcr acquisit start ep calcul use two method
determin impact prefer convert as-convert
compani data secur llc estim reuter
continu previou page
ep beat lower tax opex report total revenu compar
ex-fx pro-forma bcr ex-divestitur miss consensu estim
primarili due slightli lower revenu bd medic lifesci despit top-lin shortfal ep
ex-fx beat consensu forecast ep upsid vs model
mostli driven lower tax rate vs estim lower opex vs
estim partli off-set lower gross margin vs estim softer gross
margin reflect fx headwind less favor product mix latter includ lower sale
sale growth acceler key segment despit slight softer report sale saw
underli sale growth acceler key segment bd medic sale grew
driven improv growth medic deliveri md medic manag
sale bd lifesci ex-advanc process divestitur repres
underli growth growth acceler reflect faster growth preanalyt
system pa diagnost system bd intervent revenu grew vs
reflect acceler growth surgeri urology/crit peripher intervent pi
sale growth slow expect
growth estim note pi sale ex-lutonix grew high-singl digit impli
lutonix sale quarter yr/yr declin
maintain guidanc growth expect least stabl compani
reiter underli sale growth continu point low-end rang given
lutonix headwind also reiter ep guidanc ex-fx growth
midpoint rang full year guidanc impli sale growth
like rang view outlook assum lutonix sale remain rang
manag expect gross margin improv due fx turn
headwind slight tailwind improv mix gross margin estim closer
low-end impli guidanc rang manag see tax rate midpoint
guidanc rang impli high-teen tax rate final bottom-lin impli ep
report growth keep mind includ gore royalti
approxim half quarter forecast total sale growth ep
report growth
becton dickinson compani
price target
price target base blend ev/ebitda ebitda price-to-earnings
estim risk includ slower expect integr bcr lower expect cost save
accret bcr unexpect delay debt pay unexpect pipelin delay/setback
believ solidli posit deliv mid-singl digit top-lin growth low double-digit
bottom-lin growth forese futur
global medic devic compani oper two key segment medic life
scienc pend bcr acquisit add third leg platform intervent grew
revenu nearli pro forma underli basi
metricswfconsensuswfconsensusrevenu medic manag deliveri critic factset wfconsensusrevenu profit incom compani report secur llc estim factset visibl alpha explicitli state consensu visibl alpha may vari base broker contribut vs actual vs medic technolog
